Clovis Oncology : Acquisition/Asset Disposal - Form 8-K

8-K



UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549






... | April 14, 2023

Related Keywords

United States ,Boulder ,Colorado ,Washington ,Delaware ,Paul Gross ,Clovis Oncology Inc ,B Pharmaceuticals Gmb ,Exchange Commission On ,Group Inc ,Securities Exchange ,Clovis Oncology United Kingdom ,United States Bankruptcy Court ,Company Current Report On Form ,Nasdaq ,Company Securities ,Clovis Oncology Ireland ,Novartis ,Securities Exchange Act ,Earliest Event Reported ,Zip Code ,General Instruction ,Securities Act ,Exchange Act ,Select Market ,Clovis Oncology ,Clovis Oncology Ireland Limited ,Clovis Oncology United Kingdom Limited ,United States Bankruptcy Code ,Novartis Innovative Therapies ,Pharmaceuticals Gmbh ,Assignment Agreement ,Current Report ,Exchange Commission ,Statements Regarding Trading ,Private Securities Litigation Reform Act ,Bankruptcy Code ,Vice President ,General Counsel ,Nc Stock Exchange ,News ,Information ,Press Release ,United ,Securities ,End ,Xchange Clvsq Us1894641000 ,